CT
Cygnal Therapeutics is a biotechnology company focused on developing targeted therapies that modulate the immune system to treat various diseases. Their approach addresses the need for more effective treatments in conditions where traditional therapies have limited efficacy.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cygnal Therapeutics is a biotechnology company focused on developing targeted therapies that modulate the immune system to treat various diseases. Their approach addresses the need for more effective treatments in conditions where traditional therapies have limited efficacy.